"Exanthema" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology.
| Descriptor ID |
D005076
|
| MeSH Number(s) |
C17.800.257
|
| Concept/Terms |
Exanthema- Exanthema
- Skin Rash
- Rash, Skin
- Rash
- Exanthem
|
Below are MeSH descriptors whose meaning is more general than "Exanthema".
Below are MeSH descriptors whose meaning is more specific than "Exanthema".
This graph shows the total number of publications written about "Exanthema" by people in this website by year, and whether "Exanthema" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Exanthema" by people in Profiles.
-
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features. Rheumatology (Oxford). 2023 02 23; 62(SI2):SI226-SI234.
-
A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors. Clin Cancer Res. 2022 Mar 01; 28(5):882-892.
-
Subacute Vision Loss in a 37-Year-Old Man With a Rash. JAMA Ophthalmol. 2021 09 01; 139(9):1033-1034.
-
Case report: aseptic meningitis secondary to varicella-zoster virus (VZV) without an exanthem post MMR vaccination. BMC Infect Dis. 2021 Aug 03; 21(1):746.
-
Neonatal Toxic Shock Syndrome-Like Exanthematous Disease in North America. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):205-206.
-
Ocular manifestations of mycoplasma-induced rash and mucositis. J AAPOS. 2020 08; 24(4):249-251.
-
Cutaneous adverse reactions in B-RAF positive metastatic melanoma following sequential treatment with B-RAF/MEK inhibitors and immune checkpoint blockade or vice versa. A single-institutional case-series. J Immunother Cancer. 2019 01 08; 7(1):4.
-
Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features. Medicine (Baltimore). 2014 Nov; 93(24):318-332.
-
B lymphocyte stimulator levels in systemic lupus erythematosus: higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels. Arthritis Rheum. 2011 Dec; 63(12):3931-41.
-
Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity. Medicine (Baltimore). 2008 Mar; 87(2):70-86.